41
TITLE: Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays  Full Text
AUTHORS: Adhikari, N; Halder, AK ; Mallick, S; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2016, SOURCE: Bioorganic and Medicinal Chemistry, VOLUME: 24, ISSUE: 18
INDEXED IN: Scopus CrossRef: 47
IN MY: ORCID
42
TITLE: Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents  Full Text
AUTHORS: Mondal, C; Halder, AK ; Adhikari, N; Saha, A; Saha, KD; Gayen, S; Jha, T;
PUBLISHED: 2015, SOURCE: European Journal of Medicinal Chemistry, VOLUME: 90
INDEXED IN: Scopus CrossRef: 22
IN MY: ORCID
43
TITLE: Design of dual MMP-2/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity
AUTHORS: Halder, AK ; Mallick, S; Shikha, D; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2015, SOURCE: RSC Advances, VOLUME: 5, ISSUE: 88
INDEXED IN: Scopus CrossRef: 52
IN MY: ORCID
44
TITLE: Ligand-and structure-based drug design of non-steroidal aromatase inhibitors (NSAIs) in breast cancer
AUTHORS: Jha, T; Adhikari, N; Halder, AK ; Saha, A;
PUBLISHED: 2015, SOURCE: Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment
INDEXED IN: Scopus CrossRef: 4
IN MY: ORCID
45
TITLE: Recent advances in multi-task QSAR modeling for drug design
AUTHORS: Halder, AK ; Goodarzi, M;
PUBLISHED: 2015, SOURCE: Pharmaceutical Sciences, VOLUME: 21, ISSUE: 4
INDEXED IN: Scopus CrossRef
IN MY: ORCID
46
TITLE: Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation
AUTHORS: Halder, AK ; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2015, SOURCE: Journal of Biomolecular Structure and Dynamics, VOLUME: 33, ISSUE: 8
INDEXED IN: Scopus CrossRef: 16
IN MY: ORCID
47
TITLE: Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studies  Full Text
AUTHORS: Adhikari, N; Halder, AK ; Saha, A; Das Saha, K; Jha, T;
PUBLISHED: 2015, SOURCE: Toxicology in Vitro, VOLUME: 29, ISSUE: 7
INDEXED IN: Scopus CrossRef: 24
IN MY: ORCID
48
TITLE: Towards the development of anticancer drugs from andrographolide: Semisynthesis, bioevaluation, QSAR analysis and pharmacokinetic studies
AUTHORS: Hazra, A; Mondal, C; Chakraborty, D; Halder, AK ; Bharitkar, YP; Mondal, SK; Banerjee, S; Jha, T; Mondal, NB;
PUBLISHED: 2015, SOURCE: Current Topics in Medicinal Chemistry, VOLUME: 15, ISSUE: 11
INDEXED IN: Scopus
IN MY: ORCID
49
TITLE: Structural findings of cinnolines as anti-schizophrenic PDE10A inhibitors through comparative chemometric modeling  Full Text
AUTHORS: Mondal, C; Halder, AK ; Adhikari, N; Jha, T;
PUBLISHED: 2014, SOURCE: Molecular Diversity, VOLUME: 18, ISSUE: 3
INDEXED IN: Scopus CrossRef: 12
IN MY: ORCID
50
TITLE: Structural findings of quinolone carboxylic acids in cytotoxic, antiviral, and anti-HIV-1 integrase activity through validated comparative molecular modeling studies  Full Text
AUTHORS: Adhikari, N; Halder, AK ; Mondal, C; Jha, T;
PUBLISHED: 2014, SOURCE: Medicinal Chemistry Research, VOLUME: 23, ISSUE: 6
INDEXED IN: Scopus CrossRef: 18
IN MY: ORCID
Page 5 of 7. Total results: 67.